Search results
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 30 minutes agoThe scientists investigated the antibody neutralization response against different variants of SARS-...
Study reports new compound that halts replication of COVID by targeting 'Mac-1' protein in cell...
Medical Xpress· 2 hours agoResearch appearing in the Journal of Medicinal Chemistry shows for the first time SARS-CoV-2, the...
A Scientist Says He Has the Evidence That We Live in a Simulation
Popular Mechanics· 1 day agoMany philosophers and scientists have pondered if we live in a simulated universe, and University of...
Lungs of young adults more susceptible to SARS-CoV-2 virus: Study
Investing.com· 1 week agoLungs of young adults more susceptible to SARS-CoV-2 virus: Study
JN.1 COVID Variant Symptoms vs. Allergy Symptoms
Verywell Health via Yahoo News· 3 days agoThe JN.1 COVID variant has slightly different symptoms than other variants, as well as some differences when compared to seasonal allergies. Here's what...
How B cells recognize new variants of SARS-CoV-2
Medical Xpress· 2 days agoResearchers at TWINCORE, Center for Clinical and Experimental Infection Research, have now been able to show that the combination of infection and...
New technology uncovers mechanism affecting generation of new COVID variants
Medical Xpress· 3 days agoUnderstanding the genetic mechanism fueling SARS-CoV-2's ability to generate variants can go a long way in keeping COVID at bay. In a ...
Physicist Studying SARS-CoV-2 Virus Believes He Has Found Hints We Are Living In A Simulation
IFLScience· 1 week agoA physicist studying mutations of the SARS-CoV-2 virus claims to have found evidence for a new law...
Stanford Medicine Unmasks the Surprising Instigators of Severe COVID in the Lungs
SciTechDaily· 1 week agoA previously overlooked type of immune cell allows SARS-CoV-2 to proliferate, Stanford Medicine...
Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days
Center for Infectious Disease Research and Policy· 1 day agoTaking the SARS-CoV-2 antiviral drug nirmatrelvir-ritonavir (Paxlovid) 3 to 5 days after COVID-19...